![Immunis Chairman Dr. Hans Keirstead Delivered Keynote at the Aging and Gerontology Conference in Dubai [video]](https://immunisbiomedical.com/wp-content/uploads/2022/07/cropped-immunislogo.png)
Immunis Chairman Dr. Hans Keirstead Presents at the Rejuvenation Startup Summit in Berlin [photos]
Immunis Chairman Dr. Hans Keirstead Meets With His Holiness the Dalai Lama [photos]
Immunis Chairman Dr. Hans Keirstead Delivered Keynote at the Aging and Gerontology Conference in Dubai [video]
IRVINE, Calif. — October 24, 2022 — Immunis Inc. Chairman, Dr. Hans Keirstead, presented a keynote at the 2022 Aging and Gerontology Conference in Dubai. Please enjoy the video footage of his keynote.
About Aging and Gerontology Conference
The Aging and Gerontology conference is focused on cellular & molecular repair of age-associated disease. The conference strives to help medical professionals in the geriatric field and the public to understand, empathize and take action to aid the individuals worldwide. For additional information about the Aging and Gerontology Conference please visit: www.agingcongress.com
About Immunis Inc.
Immunis is a private biotechnology company developing a novel immunomodulatory secretome product for the various manifestations of age and disease-related immune decline. The STEM product line leverages Immunis’ leading-edge capabilities in stem cell technologies to deliver a product of all natural, all human immune modulators in their natural relative physiological concentrations. For additional information about Immunis’ IMM01-STEM Phase 1/2a trial please visit: www.immunisbiomedical.com
###